News search

Cutting-edge research and insightful commentary from world-leading experts.

62 results were found based on your search term

UK’s youngest clinical professor awarded prestigious NIHR Research Professorship
Professor Joht Chandan has been awarded a prestigious Research Professorship by the National Institute for Health and Care Research (NIHR).
- Published: 4 November 2025
New study calls for improved NHS head injury discharge advice
Researchers are developing digital health technology which could enhance future patient access to up-to-date specialist advice to better support recovery.
- Published: 16 October 2025
Birmingham Professor to co-lead new UK collaboration tackling infection and antimicrobial resistance
A national partnership with the NIHR Birmingham BRC, Oxford and Leeds will accelerate research to personalise treatment and tackle antimicrobial resistance.
- Published: 16 October 2025
University of Birmingham joins Nobel Prize winner to win major funding on chronic inflammation
Birmingham researchers will join 2025 Nobel Prize winner Professor Shimon Sakaguchi in a research programme to transform treatment of autoimmune diseases.
- Published: 8 October 2025
Birmingham clinician awarded £1.8M to develop AI-driven treatments for drug-resistant eye infections
Dr Darren Ting is awarded a five-year MRC Fellowship to use AI and nanotechnology to develop next generation treatments for drug-resistant infectious keratitis.
- Published: 12 September 2025
New strains of beneficial gut bacteria discovered in animals
Animals contain previously undiscovered strains of beneficial bacteria which could have significant benefits for both human health and animal husbandry.
- Published: 10 September 2025
Applied Health professor awarded American Thyroid Association Lectureship
Professor Kristien Boelaert has been awarded a prestigious lectureship by the American Thyroid Association for her research in thyroidology.
- Published: 2 September 2025
Adding cell-based vaccine to liver cancer therapy slows cancer progression in patients
Results of randomised Phase 2 ImmunoTACE trial saw an increase in progression-free survival time for Hepatocellular Carcinoma (HCC) patients.
- Published: 26 August 2025